Internal Medicine Education

Advancing Knowledge

Providing unmatched and enriching educational experiences for the development of all levels of learners.

Begin here, go anywhere

Education is at the heart of everything we do. Since 1848, the Department of Internal Medicine has led the vision and mission of the U-M Medical School. Our legacy of learners, residents and fellows spans generations and connects us with hospitals and institutions around the world.

In today’s ever-changing healthcare system, a career in medicine demands not only a wide breadth of knowledge and a host of special skills, but the passion and compassion that accompany the highest quality of patient care, education and research. Learn more about how we help each of our learners reach their full professional potential with the educational programs below.

Education & Training Programs

Medical Student Education

Prepare for a career in internal medicine with inpatient and outpatient rotations in a broad range of subspecialties.

Internal Medicine Residency

Train in a variety of clinical care sites with a diverse patient population.

Medicine-Pediatrics Residency

Prepare for a career in Internal Medicine and Pediatrics in our program that has pass rates of over 90%

Fellowships

The Department of Internal Medicine is home to over 22 exceptional fellowship and training programs to increase your skills and advance your career.

Medicine Grand Rounds

Every Friday throughout the academic year, the Department of Internal Medicine hosts weekly Grand Rounds to share the latest advances in internal medicine.

Browse the Medicine Grand Rounds schedule

Continuing Medical Education (CME)

Enhance your knowledge, skills and practice with regular opportunities to learn from our expert faculty members. Innovative, unbiased and evidence-based medical education activities are available in-person or virtual via live webinar and on-demand courses.

Explore Continuing Medical Education

Stay Connected With Internal Medicine

Featured News & Stories

See all news

Health Lab Podcast

Major Changes to Medicaid

With eligibility rules for people with lower incomes changing in every state, it’s important to stay up to date, seek trustworthy sources and not fall for misinformation. Read the full article here. The article this episode showcases was originally published Sept. 30 and updated Nov. 6 of 2026. The article will be kept up to date as more details become available, and the link to the full article will be included in the episode description.

Department News

Dr. John Varga Delivers Prestigious Philip Hench Memorial Lecture at ACR Convergence 2026

Dr. John Varga was selected to deliver the prestigious Philip Hench Memorial Lecture at American College of Rheumatology (ACR) Convergence 2026, recognizing his significant contributions to rheumatology research and advancing our understanding of fibrotic diseases.

A smartphone displaying a red heart with a white EKG line on its screen, set against a teal background.

Health Lab

Mobile health app improves heart failure medication use, dosing after hospitalization

A U-M-led trial found a mobile app improved use and dosing of recommended heart failure medications during the 90 days following a hospital discharge.

Health Lab

What’s changing in Medicaid and what can you do?

With eligibility rules for people with lower incomes changing in every state, it’s important to stay up to date, seek trustworthy sources and not fall for misinformation

Medical School News

Nine from Medical School honored as part of annual Faculty and Staff Awards

Michigan Medicine recently announced its 2026 Faculty and Staff Awards. This year’s recipients include nine winners with Medical School appointments, including seven faculty and two staff members. This year’s Faculty and Staff Awards ceremony will be Dec. 3 at the Jack Roth Stadium Club in Michigan Stadium

Department News

Semaglutide and Kidney Protection in Type 2 Diabetes

Published in Nature Medicine (October 2026), this randomized, placebo-controlled clinical trial investigated the kidney-protective mechanisms of semaglutide in individuals with type 2 diabetes and chronic kidney disease. The 52-week study involved 106 participants and integrated advanced kidney imaging, tissue biopsy, and molecular profiling to examine treatment-related changes in kidney health.